PRODUCT
Anti-canine CD20(144-188, ectodomain) antibody (YA183~YA187)
Overview
- Cat.No
- YA183~YA187
- Product name
- Anti-canine CD20(144-188, ectodomain) antibody
- Description
- The canine CD20 ectodomain refers to the extracellular portion of the CD20 protein, which is a cell surface marker expressed on B cells in dogs. CD20 is a key target in immunotherapy, particularly in canine B-cell lymphoma, as it plays a role in regulating B cell activation and differentiation. Therapeutic antibodies targeting the CD20 ectodomain are used in veterinary oncology to treat lymphoma and other B cell-related disorders in dogs.
- Antigen
- Synthetic peptide corresponding to canine CD20(144-188)
- Application
- ELISA
- Source
- Mammalian cells (293F)
- Form
- Mini-body (Canine IgG Fc-fused scFv)
- Storage
- PBS(pH7.3)
- Concentration
- The concentration of this product may be batch-dependent.
- Purify
- >90% as determined by SDS-PAGE and Coomassie brilliant blue staining
- Clonality
- monoclonal antibody
- Alternative name
- Reference
- Size
- 100 µg
- Price
- ￦450,000